TGFBR1 is required for mouse myometrial development

Molecular Endocrinology

Volumn 28, Issue 3, 2014, Pages 380-394

  Gao, Yang ^a   Bayless, Kayla J ^b   Li, Qinglei ^a  

^a TEXAS A AND M UNIVERSITY   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; SCLEROPROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ANIMAL CELL; ARTICLE; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; IN VITRO STUDY; MOUSE; MYOMETRIUM; NONHUMAN; POSTNATAL DEVELOPMENT; PRENATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SMOOTH MUSCLE; STROMA CELL; UTERUS; VASCULAR SMOOTH MUSCLE;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; MYOMETRIUM; PLATELET-DERIVED GROWTH FACTOR; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; STROMAL CELLS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84896867427     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2013-1284     Document Type: Article

References (72)

1. Orvis GD, Behringer RR. Cellular mechanisms of Mullerian duct formation in the mouse. Dev Biol. 2007; 306: 493-504.
2. Spencer TE, Dunlap KA, Filant J. Comparative developmental biology of the uterus: insights into mechanisms and developmental disruption. Mol Cell Endocrinol. 2012; 354: 34-53.
3. Mesiano S, Chan EC, Fitter JT, Kwek K, Yeo G, Smith R. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab. 2002; 87: 2924-2930.
4. Condon JC, Jeyasuria P, Faust JM, Wilson JW, Mendelson CR. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci USA. 2003; 100: 9518-9523.
5. Brainard AM, Miller AJ, Martens JR, England SK. Maxi-K channels localize to caveolae in human myometrium: a role for an actinchannel-caveolin complex in the regulation of myometrial smooth muscle K current. Am J Physiol Cell Physiol. 2005; 289: C49-C57.
6. Brainard AM, Korovkina VP, England SK. Potassium channels and uterine function. Semin Cell Dev Biol. 2007; 18: 332-339.
7. Yallampalli C, Dong YL. Estradiol-17β inhibits nitric oxide synthase (NOS)-II and stimulates NOS-III gene expression in the rat uterus. Biol Reprod. 2000; 63: 34-41.
8. Yallampalli C, Garfield RE, Byam-Smith M. Nitric oxide inhibits uterine contractility during pregnancy but not during delivery. Endocrinology. 1993; 133: 1899-1902.
9. Tong D, Lu X, Wang HX, et al. A dominant loss-of-function GJA1 (Cx43) mutant impairs parturition in the mouse. Biol Reprod. 2009; 80: 1099-1106.
10. Renthal NE, Chen CC, Williams KC, Gerard RD, Prange-Kiel J, Mendelson CR. miR-200 family and targets, ZEB1 and ZEB2, modulate uterine quiescence and contractility during pregnancy and labor. Proc Natl Acad Sci USA. 2010; 107: 20828-20833.
11. Brody JR, Cunha GR. Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice: I. Normal development. Am J Anat. 1989; 186: 1-20.
12. Brody JR, Cunha GR. Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice: II. Effects of DES on development. Am J Anat. 1989; 186: 21-42.
13. Mehasseb MK, Bell SC, Habiba MA. The effects of tamoxifen and estradiol on myometrial differentiation and organization during early uterine development in the CD1 mouse. Reproduction. 2009; 138: 341-350.
14. Miller C, Sassoon DA. Wnt-7a maintains appropriate uterine patterning during the development of the mouse female reproductive tract. Development. 1998; 125: 3201-3211.
15. Wang Y, Jia Y, Franken P, et al. Loss of APC function in mesenchymal cells surrounding the Mullerian duct leads to myometrial defects in adult mice. Mol Cell Endocrinol. 2011; 341: 48-54.
16. Arango NA, Szotek PP, Manganaro TF, Oliva E, Donahoe PK, Teixeira J. Conditional deletion of β-catenin in the mesenchyme of the developing mouse uterus results in a switch to adipogenesis in the myometrium. Dev Biol. 2005; 288: 276-283.
17. Parr BA, McMahon AP. Sexually dimorphic development of the mammalian reproductive tract requires Wnt-7a. Nature. 1998; 395: 707-710.
18. Massague J. The transforming growth-factor-β family. Annu Rev Cell Biol. 1990; 6: 597-641.
19. Li Q, Agno JE, Edson MA, Nagaraja AK, Nagashima T, Matzuk MM. Transforming growth factor beta receptor type 1 is essential for female reproductive tract integrity and function. PLoS Genet. 2011; 7: e1002320.
20. King KE, Iyemere VP, Weissberg PL, Shanahan CM. Kruppel-like factor 4 (KLF4/GKLF) is a target of bone morphogenetic proteins and transforming growth factor β1 in the regulation of vascular smooth muscle cell phenotype. J Biol Chem. 2003; 278: 11661-11669.
21. Kennard S, Liu H, Lilly B. Transforming growth factor-β (TGF-β1) down-regulates Notch3 in fibroblasts to promote smooth muscle gene expression. J Biol Chem. 2008; 283: 1324-1333.
22. Hu J, Gray CA, Spencer TE. Gene expression profiling of neonatal mouse uterine development. Biol Reprod. 2004; 70: 1870-1876.
23. Hu J, Zhang X, Nothnick WB, Spencer TE. Matrix metalloproteinases and their tissue inhibitors in the developing neonatal mouse uterus. Biol Reprod. 2004; 71: 1598-1604.
24. Sage EH. Regulation of interactions between cells and extracellular matrix: a command performance on several stages. J Clin Invest. 2001; 107: 781-783.
25. Hynes RO. The extracellular matrix: not just pretty fibrils. Science. 2009; 326: 1216-1219.
26. Zode GS, Sethi A, Brun-Zinkernagel AM, Chang IF, Clark AF, Wordinger RJ. Transforming growth factor-β2 increases extracellular matrix proteins in optic nerve head cells via activation of the Smad signaling pathway. Mol Vis. 2011; 17: 1745-1758.
27. Busnadiego O, Gonzalez-Santamaria J, Lagares D, et al. LOXL4 is induced by TGF-β1 through Smad and JunB/Fra2 and contributes to vascular matrix remodeling. Mol Cell Biol. 2013; 33: 2388-2401.
28. Hedin U, Roy J, Tran PK, Lundmark K, Rahman A. Control of smooth muscle cell proliferation-the role of the basement membrane. Thromb Haemost. 1999; 82 (suppl 1): 23-26.
29. Thyberg J, Hedin U, Sjolund M, Palmberg L, Bottger BA. Regulation of differentiated properties and proliferation of arterial smooth-muscle cells. Arteriosclerosis. 1990; 10: 966-990.
30. Seki T, Naito I, Oohashi T, Sado Y, Ninomiya Y. Differential expression of type IV collagen isoforms, α5 (IV) and α6 (IV) chains, in basement membranes surrounding smooth muscle cells. Histochem Cell Biol. 1998; 110: 359-366.
31. Jamin SP, Arango NA, Mishina Y, Hanks MC, Behringer RR. Requirement of Bmpr1a for Mullerian duct regression during male sexual development. Nat Genet. 2002; 32: 408-410.
32. Larsson J, Goumans MJ, Sjostrand LJ, et al. Abnormal angiogenesis but intact hematopoietic potential in TGF-β type I receptor-deficient mice. EMBO J. 2001; 20: 1663-1673.
33. Li Q, Pangas SA, Jorgez CJ, Graff JM, Weinstein M, Matzuk MM. Redundant roles of SMAD2 and SMAD3 in ovarian granulosa cells in vivo. Mol Cell Biol. 2008; 28: 7001-7011.
34. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2[-δδ C (T)] method. Methods. 2001; 25: 402-408.
35. Shynlova OP, Oldenhof AD, Liu MY, Langille L, Lye SJ. Regulation of c-fos expression by static stretch in rat myometrial smooth muscle cells. Am J Obstet Gynecol. 2002; 186: 1358-1365.
36. Daikoku T, Tranguch S, Friedman DB, Das SK, Smith DF, Dey SK. Proteomic analysis identifies immunophilin FK506 binding protein 4 (FKBP52) as a downstream target of Hoxa10 in the periimplantation mouse uterus. Mol Endocrinol. 2005; 19: 683-697.
37. Chen L, Belton RJ, Nowak RA. Basigin-mediated gene expression changes in mouse uterine stromal cells during implantation. Endocrinology. 2009; 150: 966-976.
38. Lee M, Rodansky ES, Smith JK, Rodgers GM. ADAMTS13 promotes angiogenesis and modulates VEGF-induced angiogenesis. Microvasc Res. 2012; 84: 109-115.
39. Filant J, Zhou HJ, Spencer TE. Progesterone inhibits uterine gland development in the neonatal mouse uterus. Biol Reprod. 2012; 86: 1-9.
40. Sohni A, Mulas F, Ferrazzi F, et al. TGFβ1-induced Baf60c regulates both smooth muscle cell commitment and quiescence. PloS One. 2012; 7: e47629.
41. Deaton RA, Su C, Valencia TG, Grant SR. Transforming growth factor-β1-induced expression of smooth muscle marker genes involves activation of PKN and p38 MAPK. J Biol Chem. 2005; 280: 31172-31181.
42. Elberg G, Chen L, Elberg D, Chan MD, Logan CJ, Turman MA. MKL1 mediates TGF-β1-induced α-smooth muscle actin expression in human renal epithelial cells. Am J Physiol Renal Physiol. 2008; 294: F1116-F1128.
43. Wang ZG, Wang DZ, Pipes GCT, Olson EN. Myocardin is a master regulator of smooth muscle gene expression. Proc Natl Acad Sci USA. 2003; 100: 7129-7134.
44. Schedin P, Keely PJ. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol. 2011; 3: a003228.
45. Lu P, Takai K, Weaver VM, Werb Z. Extracellular matrix degradation and remodeling in development and disease. Cold Spring Harb Perspect Biol. 2011; 3: a005058.
46. Luo X, Ding L, Xu J, Chegini N. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-β. Endocrinology. 2005; 146: 1097-1118.
47. Ma C, Chegini N. Regulation of matrix metalloproteinases (MMPs) and their tissue inhibitors in human myometrial smooth muscle cells by TGF-β1. Mol Hum Reprod. 1999; 5: 950-954.
48. Schwenke M, Knofler M, Velicky P, et al. Control of human endometrial stromal cell motility by PDGF-BB, HB-EGF and trophoblast-secreted factors. PLoS One. 2013; 8: e54336.
49. Hughes AD, Clunn GF, Refson J, Demoliou-Mason C. Plateletderived growth factor (PDGF): actions and mechanisms in vascular smooth muscle. Gen Pharmacol. 1996; 27: 1079-1089.
50. Juengel JL, McNatty KP. The role of proteins of the transforming growth factor-β superfamily in the intraovarian regulation of follicular development. Hum Reprod Update. 2005; 11: 144-161.
51. Edson MA, Nagaraja AK, Matzuk MM. The mammalian ovary from genesis to revelation. Endocr Rev. 2009; 30: 624-712.
52. Tang XM, Dou Q, Zhao Y, McLean F, Davis J, Chegini N. The expression of transforming growth factor-βs and TGF-β receptor mRNA and protein and the effect of TGF-βs on human myometrial smooth muscle cells in vitro. Mol Hum Reprod. 1997; 3: 233-240.
53. Das SK, Flanders KC, Andrews GK, Dey SK. Expression of transforming growth factor-β isoforms (β2 and β3) in the mouse uterus: analysis of the periimplantation period and effects of ovarian steroids. Endocrinology. 1992; 130: 3459-3466.
54. Ciarmela P, Wiater E, Vale W. Activin-A in myometrium: characterization of the actions on myometrial cells. Endocrinology. 2008; 149: 2506-2516.
55. Ciarmela P, Wiater E, Smith SM, Vale W. Presence, actions, and regulation of myostatin in rat uterus and myometrial cells. Endocrinology. 2009; 150: 906-914.
56. Chegini N, Luo X, Ding L, Ripley D. The expression of Smads and transforming growth factor β receptors in leiomyoma and myometrium and the effect of gonadotropin releasing hormone analogue therapy. Mol Cell Endocrinol. 2003; 209: 9-16.
57. Green AR, Styles JA, Parrott EL, et al. Neonatal tamoxifen treatment of mice leads to adenomyosis but not uterine cancer. Exp Toxicol Pathol. 2005; 56: 255-263.
58. Grainger DJ, Metcalfe JC, Grace AA, Mosedale DE. Transforming growth factor-β dynamically regulates vascular smooth muscle differentiation in vivo. J Cell Sci. 1998; 111: 2977-2988.
59. Darby I, Skalli O, Gabbiani G. α-Smooth muscle actins transiently expressed by myofibroblasts during experimental wound healing. Lab Invest. 1990; 63: 21-29.
60. Qian J, Lessard JL. Tissue and developmental specific expression of murine smooth-muscle γ-actin (Smga) fusion genes in transgenic mice. Mol Biol Cell. 1995; 6: 2427-2427.
61. Zhang JCL, Kim S, Helmke BP, et al. Analysis of SM22 α-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function. Mol Cell Biol. 2001; 21: 1336-1344.
62. Xiao QZ, Zeng LF, Zhang ZY, Hu YH, Xu QB. Stem cell-derived Sca-1 () progenitors differentiate into smooth muscle cells, which is mediated by collagen IV-integrin α (1) /β (1) /α (v) and PDGF receptor pathways. Am J Physiol Cell Physiol. 2007; 292: C342-C352.
63. Suzuki S, Narita Y, Yamawaki A, et al. Effects of extracellular matrix on differentiation of human bone marrow-derived mesenchymal stem cells into smooth muscle cell lineage: utility for cardiovascular tissue engineering. Cells Tissues Organs. 2010; 191: 269-280.
64. Thyberg J, Hultgardh-Nilsson A. Fibronectin and the basement membrane components laminin and collagen type IV influence the phenotypic properties of subcultured rat aortic smooth muscle cells differently. Cell Tissue Res. 1994; 276: 263-271.
65. Costello I, Biondi CA, Taylor JM, Bikoff EK, Robertson EJ. Smad4-dependent pathways control basement membrane deposition and endodermal cell migration at early stages of mouse development. BMC Dev Biol. 2009; 9: 54.
66. Nishinaka K, Fukuda Y. Changes in extracellular-matrix materials in the uterine myometrium of rats during pregnancy and postparturition. Acta Pathol Jpn. 1991; 41: 122-132.
67. Battegay EJ, Raines EW, Seifert RA, Bowenpope DF, Ross R. Tgf-β induces bimodal proliferation of connective-tissue cells via complex control of an autocrine Pdgf loop. Cell. 1990; 63: 515-524.
68. Marx M, Perlmutter RA, Madri JA. Modulation of platelet-derived growth-factor receptor expression in microvascular endothelial cells during in vitro angiogenesis. J Clin Invest. 1994; 93: 131-139.
69. Gaengel K, Genove G, Armulik A, Betsholtz C. Endothelial-mural cell signaling in vascular development and angiogenesis. Arterioscler Thromb Vasc Biol. 2009; 29: 630-638.
70. Dixelius J, Jakobsson L, Genersch E, Bohman S, Ekblom P, Claesson-Welsh L. Laminin-1 promotes angiogenesis in synergy with fibroblast growth factor by distinct regulation of the gene and protein expression profile in endothelial cells. J Biol Chem. 2004; 279: 23766-23772.
71. Nagaraja AK, Andreu-Vieyra C, Franco HL, et al. Deletion of Dicer in somatic cells of the female reproductive tract causes sterility. Mol Endocrinol. 2008; 22: 2336-2352.
72. Frank KM, Zhou T, Moreno-Vinasco L, Hollett B, Garcia JGN, Wardenburg JB. Host response signature to staphylococcus aureus α-hemolysin implicates pulmonary Th17 response. Infect Immun. 2012; 80: 3161-3169.